Literature DB >> 4008648

Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.

R S Schwartz, Y Tanaka, I J Fidler, D T Chiu, B Lubin, A J Schroit.   

Abstract

The precise mechanism by which sickle erythrocytes (RBC) are removed from the circulation is controversial, although it is possible that enhanced recognition of these cells by circulating mononuclear phagocytes could contribute to this process. We investigated this possibility by interacting sickle cells with cultured human peripheral blood monocytes. Our results show that both irreversibly sickled cells (ISC) and deoxygenated reversibly sickled cells (RSC) had a higher avidity for adherence to monocytes than did oxygenated sickle and normal RBC. ISC were the most adherent cell type. Adherence of RSC to monocytes was found to be reversible; reoxygenation of deoxygenated RSC resulted in a significant decrease in RSC--monocyte adherence. Concomitant with alterations in sickle RBC adherence were alterations in the organization and bilayer distribution of membrane phospholipids in these cells. Specifically, enhanced adherence was associated with increased exposure of RBC membrane outer leaflet phosphatidylserine (PS) and phosphatidylethanolamine, whereas lack of adherence was associated with normal patterns of membrane phospholipid distribution. To investigate the possibility of whether the exposure of PS in the outer membrane leaflet of these cells might be responsible for their recognition by monocytes, the membranes of normal RBC were enriched with the fluorescent PS analogue 1-acyl-2[(N-4-nitro-benzo-2-oxa-1,3-diazole)aminocaproyl]-phosphatidy lse rine (NBD-PS) via transfer of the exogenous lipid from a population of donor phospholipid vesicles (liposomes). RBC enriched with NBD-PS exhibited enhanced adherence to monocytes, whereas adherence of RBC enriched with similar amounts of NBD-phosphatidylcholine (NBD-PC) was not increased. Furthermore, preincubation of monocytes with PS liposomes resulted in a approximately 60% inhibition of ISC adherence to monocytes, whereas no inhibition occurred when monocytes were preincubated with PC liposomes. These findings strongly suggest that erythrocyte surface PS may be a ligand recognized by receptors on human peripheral blood monocytes and that abnormal exposure of PS in the outer leaflet of the RBC membrane, as found in sickle RBC, might serve to trigger their recognition by circulating monocytes. Our results further suggest that abnormalities in the organization of erythrocyte membrane phospholipids may have significant pathophysiologic implications, possibly including shortened cell survival.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008648      PMCID: PMC425555          DOI: 10.1172/JCI111913

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Red cell calcium content and transmembrane calcium movements in sickle cell anemia.

Authors:  J Palek; M Thomae; D Ozog
Journal:  J Lab Clin Med       Date:  1977-06

Review 2.  Lipid asymmetry in membranes.

Authors:  J A Op den Kamp
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

3.  32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes.

Authors:  P R McCurdy
Journal:  Blood       Date:  1969-02       Impact factor: 22.113

4.  Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.

Authors:  R P Hebbel; O Yamada; C F Moldow; H S Jacob; J G White; J W Eaton
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures.

Authors:  R Hoover; R Rubin; G Wise; R Warren
Journal:  Blood       Date:  1979-10       Impact factor: 22.113

6.  Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia.

Authors:  R P Hebbel; W J Miller
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

7.  Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells.

Authors:  S E Lux; K M John; M J Karnovsky
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Abnormalities in membrane phospholipid organization in sickled erythrocytes.

Authors:  B Lubin; D Chiu; J Bastacky; B Roelofsen; L L Van Deenen
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages.

Authors:  A Raz; C Bucana; W E Fogler; G Poste; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

10.  Abnormal rheology of oxygenated blood in sickle cell anemia.

Authors:  S Chien; S Usami; J F Bertles
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

View more
  27 in total

1.  Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 2.  Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome.

Authors:  Ximing Li; Hongliang Cong
Journal:  Tex Heart Inst J       Date:  2009

3.  Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.

Authors:  Aslihan Turhan; Linnea A Weiss; Narla Mohandas; Barry S Coller; Paul S Frenette
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).

Authors:  Ahmed A Daak; Carlton D Dampier; Beng Fuh; Julie Kanter; Ofelia A Alvarez; L Vandy Black; Melissa A McNaull; Michael U Callaghan; Alex George; Lynne Neumayr; Lee M Hilliard; Fredrick Sancilio; Adrian L Rabinowicz; Matthew M Heeney
Journal:  Blood Adv       Date:  2018-08-14

Review 5.  Of membranes and malaria: phospholipid asymmetry in Plasmodium falciparum-infected red blood cells.

Authors:  Merryn Fraser; Kai Matuschewski; Alexander G Maier
Journal:  Cell Mol Life Sci       Date:  2021-03-13       Impact factor: 9.261

6.  Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation.

Authors:  J Connor; C Bucana; I J Fidler; A J Schroit
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 7.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

8.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

9.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 10.  The role of the macrophage in apoptosis: hunter, gatherer, and regulator.

Authors:  F Jon Geske; Jenifer Monks; Lisa Lehman; Valerie A Fadok
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.